IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Inovio Pharmaceuticals Inc

CUSIP: 45773H902 | 2 institutional holders

Quarters

Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile